Skip to main content

Variable Test Performance Seen With FIT for Advanced Colorectal Neoplasia

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 3, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Sept. 3, 2024 -- Fecal immunochemical tests (FITs) have variable sensitivity and specificity for detecting advanced colorectal neoplasia (ACN), according to a study published online Sept. 3 in the Annals of Internal Medicine.

Barcey T. Levy, M.D., Ph.D., from the University of Iowa Carver College of Medicine in Iowa City, and colleagues compared the performance characteristics of five commonly used FITs (with colonoscopy as the reference standard) in a cross-sectional study in three U.S. academic medical centers and affiliated endoscopy units. Participants aged 50 to 85 years completed five different FITs before colonoscopy: four qualitative tests (Hemoccult ICT, Hemosure iFOB, OC-Light S FIT, and QuickVue iFOB) and one quantitative test (OC-Auto FIT). Test performance for ACN, defined as advanced polyps or colorectal cancer (CRC), was the primary outcome.

A total of 3,761 participants were enrolled in the study. The researchers found that 320 participants had ACN (8.5 percent), including nine (0.2 percent) with CRC. Test positivity varied from 3.9 to 16.4 percent across FITs. There was variation observed in the rates of unevaluable FITs, from 0.2 to 2.5 percent. For ACN, the sensitivity and specificity varied from 10.1 to 36.7 percent and from 85.5 to 96.6 percent, respectively. All differences in sensitivity between FITs were statistically significant apart from the difference between Hemosure iFOB and QuickVue iFOB, while all differences in specificity were statically significant. Distal location of ACN was also associated with higher FIT sensitivity.

"Our findings have implications for the benefits and cost-effectiveness of CRC screening using FIT," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2024

Read this next

Global Prevalence of Congenital Heart Disease at High Altitude ~9 Percent

THURSDAY, Sept. 26, 2024 -- The global prevalence of congenital heart disease (CHD) at high altitude is 8.97 percent, according to the results of a review presented at the...

Federal Government to Offer More Free COVID-19 Tests

WEDNESDAY, Sept. 25, 2024 -- The U.S. government is offering another round of free COVID-19 tests, which will be available by the end of September. "U.S. households will be...

Socioeconomic Factors Increase Risk for Age-Related Macular Degeneration

WEDNESDAY, Sept. 25, 2024 -- Socioeconomic factors are linked to an increased risk for age-related macular degeneration (AMD), according to a study published online July 1...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.